Header image

HIV&AIDS Theme A - Late Breaker Session (starts 9am)

Tracks
2
Tuesday, November 7, 2017
8:45 AM - 10:30 AM
Sutherland Theatrette

Speaker

Attendee1272

A Lower CD4/CD8 Ratio Is Predictive Of Subcortico-Frontal Brain Atrophy In Virally-Suppressed HIV-Infected Persons

9:00 AM - 9:15 AM

Abstract

Speaker Presentation

Audio Recording

Biography

Attendee467

Is HIV-Neuropathy The Same In Patients Treated Without Stavudine?

9:15 AM - 9:45 AM

Abstract

Speaker Presentation

Audio Recording

Biography

Attendee1213

New HIV latency reversing agents that target novel gene expression pathways

9:45 AM - 10:00 AM

Biography

Attendee580

Phase 3 Randomized, Controlled, Clinical Trial of Bictegravir Coformulated With FTC/TAF in a Fixed-Dose Combination vs Dolutegravir + FTC/TAF in Treatment-Naïve HIV-1–Positive Adults: Week 48 Results

10:00 AM - 10:15 AM

Abstract

Speaker Presentation

Audio Recording

Biography

Attendee553

A Phase 3 Randomized Controlled Clinical Trial Of Bictegravir In A Fixed-Dose Combination, B/F/Taf, Vs Abc/Dtg/3tc In Treatment-Naïve Adults At Week 48

10:15 AM - 10:30 AM

Abstract

Speaker Presentation

Audio Recording

Biography

loading